Ausgabe 3/2013
Inhalt (9 Artikel)
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Statins and Breast Cancer: Future Directions in Chemoprevention
Cesar A. Santa-Maria, Vered Stearns
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Familial Breast Cancer Risk
Kara N. Maxwell, Susan M. Domchek
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Mammographic Density: Potential as a Risk Factor and Surrogate Marker in the Clinical Setting
Celine M. Vachon, Karthik Ghosh, Kathleen R. Brandt
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Biomarker Endpoints for Early-Phase Cancer-Prevention Studies
Parijatham S. Sivasubramanian, Katherine D. Crew
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Aspirin and Breast Cancer Prevention
Matteo Lazzeroni, Marilena Petrera, Domenico Marra, Andrea DeCensi
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence
Jasmine A. McDonald, Abhishek Goyal, Mary Beth Terry
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review
Mary Playdon, Gwendolyn Thomas, Tara Sanft, Maura Harrigan, Jennifer Ligibel, Melinda Irwin
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science
Neil M. Iyengar, Clifford A. Hudis, Ayca Gucalp
Risk, Prevention, and Screening (DL Hershman, Section Editor)
Breast Surveillance of Patients with BRCA1 and BRCA2 Mutations
Ellen Warner